Peter Blume-Jensen, based in Cambridge, MA, US, is currently a President and CEO at Acrivon Therapeutics. Peter Blume-Jensen brings experience from previous roles at XTuit Pharmaceuticals, Inc., Metamark Genetics and Daiichi Sankyo. Peter Blume-Jensen holds a 1990 - 1995 Doctor Of Philosophy in Philosophy @ Uppsala University. With a robust skill set that includes Antibodies, Oncology, Cell, Immunology, Biotechnology and more. Peter Blume-Jensen has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Peter Blume-Jensen?
Find contact details for 700 million professionals.